Dynamics of DHA and EPA supplementation: incorporation into equine plasma, synovial fluid, and surfactant glycerophosphocholines
- PMID: 33866431
- DOI: 10.1007/s11306-021-01792-5
Dynamics of DHA and EPA supplementation: incorporation into equine plasma, synovial fluid, and surfactant glycerophosphocholines
Abstract
Introduction: Horses with asthma or osteoarthritis frequently receive ω-3 fatty acid supplements. Docosahexaenoic (DHA; 22:6) and eicosapentaenoic (EPA; 20:5) acids are essential ω-3 fatty acid precursors of anti-inflammatory mediators and components of structural glycerophospholipids (GPL) that act as reservoirs of these fatty acids. Analysis of the incorporation of dietary DHA + EPA into GPL pools in different body compartments has not been undertaken in horses.
Objectives: We undertook a detailed study of dietary supplementation with DHA + EPA in horses and monitored incorporation into DHA- and EPA-containing glycerophosphocholines (GPC) 38:5, 38:6, 40:5, and 40:6 in plasma, synovial fluid (SF), and surfactant.
Methods: Horses (n = 20) were randomly assigned to the supplement or control group and evaluated on days 0, 30, 60, and 90. GPC in plasma, SF, and surfactant were measured by high-resolution mass spectrometry with less than 3 ppm mass error. Validation of DHA and EPA incorporation into these GPC was conducted utilizing MS2 of the [M + Cl]- adducts of GPC.
Results: Dietary supplementation resulted in augmented levels of GPC 38:5, 38:6, 40:5, and 40:6 in all compartments. Maximum incorporation into GPCs was delayed until 60 days. Significant increases in the levels of GPC 38:5, 40:5, and 40:6, containing docosapentaenoic acid (DPA; 22:5), also was noted.
Conclusions: DHA and EPA supplementation results in augmented storage pools of ω-3 essential fatty acids in SF and surfactant GPC. This has the potential to improve the ability of anti-inflammatory mechanisms to resolve inflammatory pathways in these critical compartments involved in arthritis and asthma.
Keywords: DHA; DPA; EPA; Equine; Glycerophosphocholine.
References
-
- Abdulnour, R. E., Sham, H. P., Douda, D. N., Colas, R. A., Dalli, J., Bai, Y., Ai, X., Serhan, C. N., & Levy, B. D. (2016). Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. Mucosal Immunology, 9, 1278–1287. - PubMed
-
- Abdulrazaq, M., Innes, J. K., & Calder, P. C. (2017). Effect of omega-3 polyunsaturated fatty acids on arthritic pain: A systematic review. Nutrition, 39–40, 57–66. - PubMed
-
- Adler, N., Schoeniger, A., & Fuhrmann, H. (2018). Polyunsaturated fatty acids influence inflammatory markers in a cellular model for canine osteoarthritis. Journal of Animal Physiology and Animal Nutrition (Berlin), 102, e623–e632.
-
- Bligh, E. G., & Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology, 37, 911–917. - PubMed
-
- Bullone, M., Vargas, A., Elce, Y., Martin, J. G., & Lavoie, J. P. (2017). Fluticasone/salmeterol reduces remodelling and neutrophilic inflammation in severe equine asthma. Science and Reports, 7, 8843.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials